bioRxivBiochemistryPreprint
Platelet and releasate lipidomics identify novel platelet activating mechanisms and ether-linked lysophosphatidylcholine and phosphatidylethanolamine 38:7 as predictors for platelet reactivity
Abstract
The activation of platelets and consequent thrombi formation are hallmark events for cardiovascular diseases. Both the secretion of lipid (in the platelet releasate) and intra-platelet lipid signaling have been shown to be important modulators to platelet activity and thrombosis. However, the relationship between platelet and releasate lipid profiles and how they respond to key agonists remain less clear. With a purposely designed human platelet targeted lipidomics platform which detected more than 550 platelet and releasate lipid species encompassing >30 lipid classes/subclasses, I presented in this study major changes to platelet lipidome triggered by acute and prolonged thrombin and collagen stimulations. I have demonstrated that overall lipid release from platelets was suppressed by collagen at the acute phase, a phenomenon that to my knowledge has yet to be reported. Additionally, prolonged thrombin treatment did not cause further production of lipid mediators. It nevertheless triggered an overall release of lipid into the surrounding (as releasate), including several proinflammatory and apoptotic lipids e.g., DG, ceramide, S1P, PA. Correlation tests between platelet/releasate lipid profiles and platelet surface markers P-selectin and PAC1 suggested that several di-/polyunsaturated phospholipid species and CoQ negatively correlated with collagen-stimulated PAC1 expression and PI 40:4(b) positively correlated with collagen-stimulated P-selectin expression. Finally, our study identified one lipid class, LPC-O, and one lipid species, PE 38:7, as potential predictors for the reactivity of platelet, with platelet LPC-O level positively correlated with collagen-stimulated increment of surface PAC1 expression and PE 38:7 correlated negatively with the increase in surface P-selectin in response to thrombin treatment.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Shear-Mediated Platelet Activation is Accompanied by Unique Alterations of Platelet Lipid Profile
A. Sweedo, L. M. Wise, … J. G. Purdy·bioRxiv·Jan 8, 2021
- Nitric oxide inhibits platelet adhesion to platelet-microparticles through reducing integrin αIIbβ3 activation
Deanna Howley, James Salt, … Wayne Roberts·bioRxiv·Aug 1, 2026
- Notch signaling functions in non-canonical juxtacrine manner in platelets to amplify thrombogenicity
S. N. Chaurasia, M. Ekhlak, … D. Dash·bioRxiv·May 6, 2022
- Very high-density platelets determine reactivity and activity of circulating platelets
P. Järemo·bioRxiv·Aug 9, 2018
- High Mobility Group Box 1 enhances ADP-mediated platelet activation by increasing platelet surface P2Y12 localization
D. Nolfi-Donegan, G. Annarapu, … S. Shiva·bioRxiv·Mar 24, 2021
- Pro-coagulant lipids in physiological ratios found in the activated platelet membrane do not impact clot structure or fibrinolysis in purified assays.
Bethan Morgan, Laura E Farleigh Smith, … Valerie B. O’Donnell·Journal of Blood MedicinePeer-reviewed·Nov 1, 2025